Ferric Maltol Patent Expiration

Ferric Maltol is used for treating iron deficiency. It was first introduced by Shield Tx Uk Ltd in its drug Accrufer on Jul 25, 2019.

Ferric Maltol Patents

Given below is the list of patents protecting Ferric Maltol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Accrufer	US9802973	Crystalline forms of ferric maltol	Oct 23, 2035	Shield Tx
Accrufer	US10179120	Dosage regimen of ferric trimaltol	Jan 06, 2035	Shield Tx
Accrufer	US9248148	Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and GI inflammation inhibiting agents) compositions for anaemia or H. pylori infections	Mar 29, 2031	Shield Tx

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List